NUREXONE BIOLOGIC INC.

Profile

Company Names

NUREXONE BIOLOGIC INC.

Addresses

MINUS 1 ENTRY, GROUND FLOOR OF BLDG B, GUTWIRTH INDUSTRIAL PARK, TECHNION CITY, HAIFA, L3 3200003

9 MEZADA STREET, BSR 3 TOWER, 30TH FLOOR, BNEI-BRAK, L3 5120109

9 MEZADA STREET, BSR 3 TOWER, 30 FLOOR, BNEI-BRAK, L3 5120109

Phone Numbers

972 52-4803034

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

ALBERTA, CANADA

Total Amount Raised:

$6,276,513.00

Number of Funding Rounds:

10
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
10
2026-06-30 
$441,779.00 
$441,779.00 
$0.00 
Equity 
9
2026-03-10 
$279,910.00 
$279,910.00 
$0.00 
Equity 
8
2025-08-20 
$147,846.00 
$243,231.00 
$95,385.00 
Equity 
7
2025-04-09 
$1,627,604.00 
$3,756,009.00 
$2,128,405.00 
Equity 
6
2025-01-21 
$434,512.00 
$434,512.00 
$0.00 
Equity 
5
2024-03-22 
$42,634.00 
$42,634.00 
$0.00 
Equity 
4
2024-03-21 
$1,018,224.00 
$1,018,224.00 
$0.00 
 
3
2024-03-20 
$430,296.00 
$430,296.00 
$0.00 
Equity 
2
2024-01-04 
$1,111,542.00 
$2,500,969.00 
$1,389,427.00 
Equity 
1
2023-08-25 
$742,166.00 
$742,166.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
YORAM 
 
DRUCKER 
EXECUTIVE OFFICER, DIRECTOR
YORAM 
40 
DRUCKER 
DIRECTOR
EYAL 
 
GABBAI 
DIRECTOR
ODED 
 
ORGIL 
DIRECTOR
ERAN 
 
OVADYA 
EXECUTIVE OFFICER
GADI 
 
RIESENFELD 
DIRECTOR
LIOR 
 
SHALTIEL 
DIRECTOR, EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2026-06-30 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2026-03-10 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-08-20 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-04-09 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-01-21 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-03-22 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2024-03-21 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-03-20 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-01-04 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-08-25 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#